Incidence and outcome of COVID-19 in patients with schizophrenia: A Study from India
- PMID: 34388517
- PMCID: PMC8346351
- DOI: 10.1016/j.schres.2021.08.002
Incidence and outcome of COVID-19 in patients with schizophrenia: A Study from India
Conflict of interest statement
None.
Similar articles
-
COVID 19 vaccination of persons with schizophrenia in India - Need for imperative action!Schizophr Res. 2021 May;231:49-50. doi: 10.1016/j.schres.2021.03.003. Epub 2021 Mar 19. Schizophr Res. 2021. PMID: 33752107 Free PMC article. No abstract available.
-
Severe COVID-19 increases the risk of schizophrenia.Psychiatry Res. 2022 Nov;317:114809. doi: 10.1016/j.psychres.2022.114809. Epub 2022 Aug 24. Psychiatry Res. 2022. PMID: 36037742 Free PMC article.
-
Demographic and Clinical Factors Related to Severe COVID-19 Infection and Mortality in Patients With Schizophrenia.J Nerv Ment Dis. 2022 Apr 1;210(4):257-263. doi: 10.1097/NMD.0000000000001500. J Nerv Ment Dis. 2022. PMID: 35212665 Free PMC article.
-
Seropositivity Against SARS-Cov-2 Infection in India: A Systematic Review and Meta Analysis.Asia Pac J Public Health. 2022 Nov;34(8):832-835. doi: 10.1177/10105395221115147. Epub 2022 Jul 25. Asia Pac J Public Health. 2022. PMID: 35880305 No abstract available.
-
The SARS-CoV-2/COVID-19 pandemic and challenges in stroke care in India.Ann N Y Acad Sci. 2020 Aug;1473(1):3-10. doi: 10.1111/nyas.14379. Epub 2020 May 12. Ann N Y Acad Sci. 2020. PMID: 32396683 Free PMC article. Review.
Cited by
-
How Did the Mental Health Care System in India Respond to COVID 19 Pandemic?Schizophr Bull Open. 2022 Oct 18;3(1):sgac043. doi: 10.1093/schizbullopen/sgac043. eCollection 2022 Jan. Schizophr Bull Open. 2022. PMID: 36348643 Free PMC article. Review.
-
Clozapine and COVID-19 Vaccination: Effects on blood levels and leukocytes. An observational cohort study.Acta Psychiatr Scand. 2022 Aug;146(2):168-178. doi: 10.1111/acps.13428. Epub 2022 Apr 1. Acta Psychiatr Scand. 2022. PMID: 35322409 Free PMC article.
-
Clozapine Therapy and COVID-19: A Systematic Review of the Prevalence Rates, Health Outcomes, Hematological Markers, and Patient Perspectives.Schizophr Bull. 2023 Jan 3;49(1):53-67. doi: 10.1093/schbul/sbac148. Schizophr Bull. 2023. PMID: 36242537 Free PMC article.
References
-
- Fond G., Pauly V., Leone M., Llorca P.-M., Orleans V., Loundou A., Lancon C., Auquier P., Baumstarck K., Boyer L. Disparities in intensive care unit admission and mortality among patients with schizophrenia and COVID-19: a National Cohort Study. Schizophr. Bull. 2021;47:624–634. doi: 10.1093/schbul/sbaa158. - DOI - PMC - PubMed
-
- Ji W., Huh K., Kang M., Hong J., Bae G.H., Lee R., Na Y., Choi H., Gong S.Y., Choi Y.-H., Ko K.-P., Im J.-S., Jung J. Effect of underlying comorbidities on the infection and severity of COVID-19 in Korea: a Nationwide case-control study. J. Korean Med. Sci. 2020;35 doi: 10.3346/jkms.2020.35.e237. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical